United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 1998 NY Rulings > NY 890820 - NY 890968 > NY 890903

Previous Ruling Next Ruling
NY 890903

November 4, 1993

CLA-2-29:S:N:N7:239 890903


TARIFF NO.: 2942.00.5000

Mr. Marshall V. Miller
Miller & Company P.C.
2320 Commerce Tower
911 Main Street
Kansas City, MO 64105

RE: The tariff classification of gadoteridol (CAS# 120066-54-8) and calteridol calcium (CAS# 121915-83-1) from Ireland.

Dear Mr. Miller:

In your letter dated October 5, 1993, and written on behalf of your client, Bristol-Myers Squibb Company, you requested a tariff classification ruling for gadoteridol and calteridol calcium.

Gadoteridol is the gadolinium complex of 10-(2-hydroxypropyl)- 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid. Calteridol calcium is the calcium salt of the calcium complex of 10-(2-hydroxypropyl)-1,4,7,10- tetraazacyclododecane-1,4,7-triacetic acid. Both products are used as MRI contrasting agents.

The applicable subheading for gadoteridol and calteridol calcium will be 2942.00.5000, Harmonized Tariff Schedule of the United States (HTS), which provides for other organic compounds. The rate of duty will be 3.7 percent ad valorem.

This ruling is being issued under the provisions of Section 177 of the Customs Regulations (19 C.F.R. 177).

A copy of this ruling letter should be attached to the entry documents filed at the time this merchandise is imported. If the documents have been filed without a copy, this ruling should be brought to the attention of the Customs officer handling the transaction.


Jean F. Maguire

Previous Ruling Next Ruling

See also: